193 related articles for article (PubMed ID: 14665473)
1. Drug therapy for pulmonary arterial hypertension: what's on the menu today?
Mehta S
Chest; 2003 Dec; 124(6):2045-9. PubMed ID: 14665473
[No Abstract] [Full Text] [Related]
2. [Pulmonary hypertension].
Kovacs G; Olschewski H
Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
[No Abstract] [Full Text] [Related]
3. Report from the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001.
Fleming T; Lindenfeld J; Lipicky R; Armstrong P
Circulation; 2001 Oct; 104(15):1742. PubMed ID: 11591605
[No Abstract] [Full Text] [Related]
4. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.
Humbert M; Barst RJ; Robbins IM; Channick RN; Galiè N; Boonstra A; Rubin LJ; Horn EM; Manes A; Simonneau G
Eur Respir J; 2004 Sep; 24(3):353-9. PubMed ID: 15358690
[TBL] [Abstract][Full Text] [Related]
5. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension.
Shimizu M; Imanishi J; Takano T; Miwa Y
Intern Med; 2011; 50(20):2341-6. PubMed ID: 22001462
[TBL] [Abstract][Full Text] [Related]
6. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS
Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026
[TBL] [Abstract][Full Text] [Related]
7. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pulmonary arterial hypertension: a preliminary decision analysis.
Highland KB; Strange C; Mazur J; Simpson KN
Chest; 2003 Dec; 124(6):2087-92. PubMed ID: 14665484
[TBL] [Abstract][Full Text] [Related]
9. Oral prostacyclin therapy for pulmonary arterial hypertension: another step forward.
Waxman AB
Circulation; 2013 Feb; 127(5):563-5. PubMed ID: 23307828
[No Abstract] [Full Text] [Related]
10. [Bosentan: a new pillar in the treatment of pulmonary hypertension?].
Matthes J; Groner F
Dtsch Med Wochenschr; 2006 May; 131(18):1031-4. PubMed ID: 16673229
[No Abstract] [Full Text] [Related]
11. Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study.
Kemp K; Savale L; O'Callaghan DS; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
J Heart Lung Transplant; 2012 Feb; 31(2):150-8. PubMed ID: 22138355
[TBL] [Abstract][Full Text] [Related]
12. Bosentan for pulmonary arterial hypertension.
Drug Ther Bull; 2003 Sep; 41(9):70-2. PubMed ID: 14531210
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of mild, but symptomatic pulmonary hypertension].
Reichenberger F; Seeger W; Nitschmann S
Internist (Berl); 2009 Mar; 50(3):374-6. PubMed ID: 19225745
[No Abstract] [Full Text] [Related]
14. Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era.
Jacobs W; Boonstra A; Brand M; Rosenberg DM; Schaaf B; Postmus PE; Vonk Noordegraaf A
J Heart Lung Transplant; 2010 Oct; 29(10):1150-8. PubMed ID: 20580264
[TBL] [Abstract][Full Text] [Related]
15. Improving survival in pulmonary arterial hypertension.
Humbert M
Eur Respir J; 2005 Feb; 25(2):218-20. PubMed ID: 15684283
[No Abstract] [Full Text] [Related]
16. [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
Nielsen-Kudsk JE
Ugeskr Laeger; 2003 Jul; 165(29):2891-4. PubMed ID: 12908360
[TBL] [Abstract][Full Text] [Related]
17. Bosentan.
Chin K; Channick R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):175-82. PubMed ID: 15151466
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pulmonary arterial hypertension: a step forward.
Sharma S
Chest; 2003 Jul; 124(1):8-11. PubMed ID: 12853493
[No Abstract] [Full Text] [Related]
19. [Pharmacological and clinical profile of treprostinil (TREPROST® for injection)].
Saito R; Ohmori Y
Nihon Yakurigaku Zasshi; 2016 Jan; 147(1):56-62. PubMed ID: 26753860
[No Abstract] [Full Text] [Related]
20. A new era in the treatment of primary pulmonary hypertension.
Bailey CL; Channick RN; Rubin LJ
Heart; 2001 Mar; 85(3):251-2. PubMed ID: 11179256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
